Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Allocation to 5 further years of AIT reduced subsequent distant recurrence rates by about a quarter despite substantial ...

Countries have a legal obligation to combat climate change. The challenge for health is to make sure that they comply. Udani ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

Professor Sir Tumani Corrah is the Emeritus Director of the Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene & Tropical Medicine (LSHTM) and founder and Co-President of ...

Overtreatment is considered harmful in terms of decreasing quality of life, wasting resources, and environmental damage.1–3 ...

Lfx therapy is a cost-saving strategy to reduce the incidence of active disease in household contacts of MDR/RR-TB in a ...

While children with comorbid conditions were at higher risk of RSV-hospitalisation, the importance of socio-demographic risk ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

On July 17, 2025, the US Food and Drug Administration (FDA) authorised marketing of five Juul e-cigarette products to adults, ...

We read with interest the Article by David J Werring and colleagues,1 which provides evidence that early initiation of direct oral anticoagulants (DOACs) after ischaemic stroke associated with atrial ...